Vaxzevria Highly Effective against Beta/Gamma and Delta Variants
Real-world data has shown the Vaxzevria vaccine (formerly AZD1222), co-developed by AstraZeneca, the University of Oxford and its spin-out company,
Read more
recombinant adenovirus vectors
Panacea Biotec and RDIF to Produce 100 Million Sputnik V vaccine Doses Yearly
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Panacea Biotec, India’s largest vaccine and pharmaceutical manufacturer, have
Read more
J&J’s COVID-19 single-shot jab approved by the FDA for Emergency Use
The U.S. FDA has approved the first single-shot COVID-19 jab, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson,
Read more
UK approves AstraZeneca and Oxford University COVID-19 vaccine
Drug regulators in the United Kingdom have approved a second COVID-19 vaccine for emergency use today, for the active immunisation
Read more
AstraZeneca to supply up to 400 million doses of Oxford’s vaccine free
AstraZeneca has come to an agreement with the European Inclusive Vaccines Alliance (IVA), initiated by Germany, France, Italy and the
Read more
AstraZeneca reaches $750m agreement with CEPI for Oxford COVID-19 vaccine
British pharmaceutical company AstraZeneca has reached a landmark $750 million agreement with Coalition for Epidemic Preparedness Innovation (CEPI) and the
Read more
AstraZeneca to advance Oxford’s COVID-19 vaccine with $1bn investment
AstraZeneca is going to expedite the development of the University of Oxford investigational COVID-19 vaccine with a $1 billion BARDA
Read more